Session » Plenary III
- 9:00AM-10:30AM
-
Abstract Number: 2528
Activation of the Hes1/Piezo1 Pathway Promotes Mechanical Stress Response and Prevents Glucocorticoid-induced Osteoporosis
- 9:00AM-10:30AM
-
Abstract Number: 2531
CRISPR Deletion Screen in Fibroblasts Identifies Novel Regulators of Inflammation
- 9:00AM-10:30AM
-
Abstract Number: 2527
Efficacy and Safety of Nipocalimab, an Anti-FcRn Monoclonal Antibody, in Primary Sjogren’s Disease: Results from a Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study (DAHLIAS)
- 9:00AM-10:30AM
-
Abstract Number: 2529
Improving Outcomes and Narrowing Disparities in Juvenile Idiopathic Arthritis (JIA): A Division-Wide, Equity-Focused Quality Improvement Project
- 9:00AM-10:30AM
-
Abstract Number: 2532
Mortality in Patients with Pre-existing Autoimmune Disease on Immune Checkpoint Inhibitor Therapy
- 9:00AM-10:30AM
-
Abstract Number: 2530
Single-cell Multi-omics Analysis of Reactive Lymph Nodes, Affected Tissues, and Blood Reveals a Naive-like CD4+TRAIL+ T Cell Population That Differentially Directs Effector Anti-nuclear Antigen Reactive Responses in Patients with Sjogren’s Syndrome and Systemic Sclerosis